Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE

ETHINYL ESTRADIOL; NORETHINDRONE ACETATE

Standard Dose
0.02MG;1MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE is listed in Drugs@FDA under application 214292 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient ETHINYL ESTRADIOL; NORETHINDRONE ACETATE Form and strength CAPSULE;ORAL - 0.02MG;1MG Sponsor AMNEAL PHARMS Submission history Latest submission status date: 2023-09-28 00:00:00.

Structured Monograph

Clinical summary

Approval overview NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE is listed in Drugs@FDA under application 214292 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ETHINYL ESTRADIOL; NORETHINDRONE ACETATE Form and strength CAPSULE;ORAL - 0.02MG;1MG Sponsor AMNEAL PHARMS Submission history Latest submission status date: 2023-09-28 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.